Deccan Health Care Limited (BOM:542248)
India · Delayed Price · Currency is INR 12.45
-0.64 (-4.89%)
At close: Aug 17, 2026
Deccan Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 292 | 160 | 345 | 563 | 469 | 562 | |
Market Cap Growth | -26.56% | -53.51% | -38.67% | 20.08% | -16.57% | 21.60% |
Enterprise Value | 315 | 161 | 338 | 559 | 422 | 541 |
Last Close Price | 12.45 | 6.85 | 16.94 | 27.62 | 27.50 | 35.75 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 12.13 | 6.45 | 29.79 | 37.71 | 153.12 | 174.13 |
PS Ratio | 0.36 | 0.20 | 0.46 | 0.94 | 1.04 | 1.69 |
PB Ratio | 0.26 | 0.15 | 0.32 | 0.58 | 0.57 | 0.73 |
P/TBV Ratio | 0.26 | 0.15 | 0.32 | 0.58 | 0.57 | 0.73 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.38 | 0.20 | 0.45 | 0.94 | 0.94 | 1.63 |
EV/EBITDA Ratio | 5.95 | 3.17 | 10.74 | 14.92 | 21.51 | 9.39 |
EV/EBIT Ratio | 8.24 | 4.45 | 19.92 | 24.49 | 78.93 | 12.62 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.01 | 0.02 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.75 | 0.78 | 0.36 | 0.51 | 0.82 | 0.22 |
Net Debt / Equity Ratio | 0.02 | 0.02 | -0.02 | -0.01 | 0.00 | -0.02 |
Net Debt / EBITDA Ratio | 0.44 | 0.45 | -0.76 | -0.19 | 0.11 | -0.25 |
Net Debt / FCF Ratio | - | -0.37 | 0.36 | 0.06 | -0.03 | 2.07 |
Asset Turnover | - | 0.60 | 0.64 | 0.58 | 0.48 | 0.36 |
Inventory Turnover | - | 1.13 | 1.08 | 0.81 | 0.54 | 0.32 |
Quick Ratio | - | 0.55 | 1.02 | 1.67 | 1.14 | 1.48 |
Current Ratio | - | 3.81 | 6.77 | 11.76 | 6.45 | 6.48 |
Return on Equity (ROE) | - | 2.30% | 1.14% | 1.67% | 0.39% | 0.42% |
Return on Assets (ROA) | - | 1.65% | 0.91% | 1.39% | 0.36% | 2.93% |
Return on Invested Capital (ROIC) | 2.60% | 2.55% | 1.21% | 1.73% | 0.47% | 3.40% |
Return on Capital Employed (ROCE) | - | 3.20% | 1.60% | 2.30% | 0.60% | 5.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 8.71% | 15.50% | 3.36% | 2.65% | 0.65% | 0.57% |
FCF Yield | -21.22% | -38.57% | -19.55% | -22.73% | -14.43% | -1.22% |
Buyback Yield / Dilution | 1.74% | 4.35% | -38.37% | -45.91% | 18.83% | - |